Skip to content
2000
Volume 24, Issue 1
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Central nervous system (CNS) diseases, including ischemic stroke (IS), Alzheimer’s disease (AD), and Parkinson’s disease (PD), are leading causes of global disability and mortality, characterized by progressive neuronal loss and irreversible neural circuit damage. Despite advances in understanding their pathophysiology, therapeutic options remain limited due to the complexity of disease mechanisms and challenges in delivering treatments across the blood-brain barrier (BBB). In this context, astrocyte reprogramming has emerged as a groundbreaking strategy for neural repair. By leveraging the plasticity of astrocytes, researchers have demonstrated the potential to convert these glial cells into functional neurons, offering a novel approach to replenish lost neurons and restore neural function. This review explores the latest advancements in astrocyte reprogramming, focusing on transcription factor-mediated, miRNA-induced, and small molecule-based strategies, as well as the molecular mechanisms underlying this process. We also discuss the therapeutic potential of astrocyte reprogramming in CNS diseases, including IS, AD, PD, and other neurodegenerative disorders, while addressing the challenges and future directions for clinical translation. Through a systematic analysis of recent studies, this review highlights the promise of astrocyte reprogramming as a transformative therapeutic strategy for CNS repair, providing new hope for patients with debilitating neurological conditions.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X379061250415094751
2025-05-08
2026-02-27

  • From This Site

    /content/journals/cn/10.2174/011570159X379061250415094751
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. WangF. ChengL. ZhangX. Reprogramming glial cells into functional neurons for neuro-regeneration: Challenges and promise.Neurosci. Bull.202137111625163610.1007/s12264‑021‑00751‑3 34283396
     [Google Scholar]
  2. WanW. AoX. ChenQ. YuY. AoL. XingW. GuoW. WuX. PuC. HuX. LiZ. YaoM. LuoD. XuX. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer.Mol. Cancer20222116010.1186/s12943‑021‑01447‑y 35197058
     [Google Scholar]
  3. WuH. ZhangT. LiN. GaoJ. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges.J. Control. Release202336016918410.1016/j.jconrel.2023.06.023 37343724
     [Google Scholar]
  4. FanY. ChenZ. ZhangM. Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases.J. Transl. Med.202220129110.1186/s12967‑022‑03493‑6 35761337
     [Google Scholar]
  5. ZhangX. LiH. ZhaoY. ZhaoT. WangZ. TangQ. Neuronal injury after ischemic stroke: Mechanisms of crosstalk involving necroptosis.J. Mol. Neurosci.20257511510.1007/s12031‑025‑02313‑y 39903429
     [Google Scholar]
  6. LiuX. WuW. LiX. WangC. ChaiK. YuanF. ZhengH. YaoY. LiC. YeZ.C. ZhaD. The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer’s disease.Neural Regen. Res.202520113330334410.4103/NRR.NRR‑D‑23‑01890 39715098
     [Google Scholar]
  7. ZhangY. MoC. AiP. HeX. XiaoQ. YangX. Pharmacomicrobiomics: A new field contributing to optimizing drug therapy in Parkinson’s disease.Gut Microbes2025171245493710.1080/19490976.2025.2454937 39875349
     [Google Scholar]
  8. LiW. ChengJ. HeF. ZhangP. ZhangN. WangJ. SongQ. HouY. GanZ. Cell membrane-based nanomaterials for theranostics of central nervous system diseases.J. Nanobiotechnology202321127610.1186/s12951‑023‑02004‑z 37596631
     [Google Scholar]
  9. ToaderC. DumitruA.V. EvaL. SerbanM. Covache-BusuiocR.A. CiureaA.V. Nanoparticle strategies for treating cns disorders: A comprehensive review of drug delivery and theranostic applications.Int. J. Mol. Sci.202425241330210.3390/ijms252413302 39769066
     [Google Scholar]
  10. LiuT. LiX. ZhouX. ChenW. WenA. LiuM. DingY. PI3K/AKT signaling and neuroprotection in ischemic stroke: Molecular mechanisms and therapeutic perspectives.Neural Regen. Res.202520102758277510.4103/NRR.NRR‑D‑24‑00568 39435629
     [Google Scholar]
  11. SharmaC. KimS. EoH. KimS.R. Recovery of the injured neural system through gene delivery to surviving neurons in Parkinson’s disease.Neural Regen. Res.202520102855286110.4103/NRR.NRR‑D‑24‑00724 39610091
     [Google Scholar]
  12. WeiJ. WangM. LiS. HanR. XuW. ZhaoA. YuQ. LiH. LiM. ChiG. Reprogramming of astrocytes and glioma cells into neurons for central nervous system repair and glioblastoma therapy.Biomed. Pharmacother.202417611680610.1016/j.biopha.2024.116806 38796971
     [Google Scholar]
  13. GaoF. LiJ-J. TalifuZ. LiuJ-Y. PanY-Z. KeH. ZhangC-J. XuX. YuY. DuL-J. In vivo astrocyte-to-neuron reprogramming for central nervous system regeneration: A narrative review.Neural Regen. Res.202318475075510.4103/1673‑5374.353482 36204831
     [Google Scholar]
  14. ChenY.C. MaN.X. PeiZ.F. WuZ. Do-MonteF.H. KeefeS. YellinE. ChenM.S. YinJ.C. LeeG. Minier-ToribioA. HuY. BaiY.T. LeeK. QuirkG.J. ChenG.A. NeuroD1 AAV-based gene therapy for functional brain repair after ischemic injury through in vivo astrocyte-to-neuron conversion.Mol. Ther.202028121723410.1016/j.ymthe.2019.09.003 31551137
     [Google Scholar]
  15. WeiZ.Y.D. ShettyA.K. Treating Parkinson’s disease by astrocyte reprogramming: Progress and challenges.Sci. Adv.2021726eabg319810.1126/sciadv.abg3198 34162545
     [Google Scholar]
  16. SikoraE. Bielak-ZmijewskaA. DudkowskaM. KrzystyniakA. MosieniakG. WesierskaM. WlodarczykJ. Cellular senescence in brain aging.Front. Aging Neurosci.20211364692410.3389/fnagi.2021.646924 33732142
     [Google Scholar]
  17. OrreM. KamphuisW. OsbornL.M. JansenA.H.P. KooijmanL. BossersK. HolE.M. Isolation of glia from Alzheimer’s mice reveals inflammation and dysfunction.Neurobiol. Aging201435122746276010.1016/j.neurobiolaging.2014.06.004 25002035
     [Google Scholar]
  18. JyothiH.J. VidyadharaD.J. MahadevanA. PhilipM. ParmarS.K. ManohariS.G. ShankarS.K. RajuT.R. AlladiP.A. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta.Neurobiol. Aging201536123321333310.1016/j.neurobiolaging.2015.08.024 26433682
     [Google Scholar]
  19. John LinC.C. YuK. HatcherA. HuangT.W. LeeH.K. CarlsonJ. WestonM.C. ChenF. ZhangY. ZhuW. MohilaC.A. AhmedN. PatelA.J. ArenkielB.R. NoebelsJ.L. CreightonC.J. DeneenB. Identification of diverse astrocyte populations and their malignant analogs.Nat. Neurosci.201720339640510.1038/nn.4493 28166219
     [Google Scholar]
  20. BayraktarO.A. FuentealbaL.C. Alvarez-BuyllaA. RowitchD.H. Astrocyte development and heterogeneity.Cold Spring Harb. Perspect. Biol.201571a02036210.1101/cshperspect.a020362 25414368
     [Google Scholar]
  21. ClarkeL.E. BarresB.A. Emerging roles of astrocytes in neural circuit development.Nat. Rev. Neurosci.201314531132110.1038/nrn3484 23595014
     [Google Scholar]
  22. HeinsN. MalatestaP. CecconiF. NakafukuM. TuckerK.L. HackM.A. ChapoutonP. BardeY.A. GötzM. Glial cells generate neurons: The role of the transcription factor Pax6.Nat. Neurosci.20025430831510.1038/nn828 11896398
     [Google Scholar]
  23. BerningerB. CostaM.R. KochU. SchroederT. SutorB. GrotheB. GötzM. Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia.J. Neurosci.200727328654866410.1523/JNEUROSCI.1615‑07.2007 17687043
     [Google Scholar]
  24. HeinrichC. BlumR. GascónS. MasserdottiG. TripathiP. SánchezR. TiedtS. SchroederT. GötzM. BerningerB. Directing astroglia from the cerebral cortex into subtype specific functional neurons.PLoS Biol.201085e100037310.1371/journal.pbio.1000373 20502524
     [Google Scholar]
  25. AddisR.C. HsuF.C. WrightR.L. DichterM.A. CoulterD.A. GearhartJ.D. Efficient conversion of astrocytes to functional midbrain dopaminergic neurons using a single polycistronic vector.PLoS One2011612e2871910.1371/journal.pone.0028719 22174877
     [Google Scholar]
  26. NiuW. ZangT. ZouY. FangS. SmithD.K. BachooR. ZhangC.L. In vivo reprogramming of astrocytes to neuroblasts in the adult brain.Nat. Cell Biol.201315101164117510.1038/ncb2843 24056302
     [Google Scholar]
  27. TorperO. PfistererU. WolfD.A. PereiraM. LauS. JakobssonJ. BjörklundA. GrealishS. ParmarM. Generation of induced neurons via direct conversion in vivo.Proc. Natl. Acad. Sci. USA2013110177038704310.1073/pnas.1303829110 23530235
     [Google Scholar]
  28. SofroniewM.V. Molecular dissection of reactive astrogliosis and glial scar formation.Trends Neurosci.2009321263864710.1016/j.tins.2009.08.002 19782411
     [Google Scholar]
  29. RobelS. BerningerB. GötzM. The stem cell potential of glia: Lessons from reactive gliosis.Nat. Rev. Neurosci.20111228810410.1038/nrn2978 21248788
     [Google Scholar]
  30. SofroniewM.V. VintersH.V. Astrocytes: Biology and pathology.Acta Neuropathol.2010119173510.1007/s00401‑009‑0619‑8 20012068
     [Google Scholar]
  31. GuoZ. ZhangL. WuZ. ChenY. WangF. ChenG. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model.Cell Stem Cell201414218820210.1016/j.stem.2013.12.001 24360883
     [Google Scholar]
  32. LiuY. MiaoQ. YuanJ. HanS. ZhangP. LiS. RaoZ. ZhaoW. YeQ. GengJ. ZhangX. ChengL. Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo.J. Neurosci.201535259336935510.1523/JNEUROSCI.3975‑14.2015 26109658
     [Google Scholar]
  33. SuZ. NiuW. LiuM.L. ZouY. ZhangC.L. In vivo conversion of astrocytes to neurons in the injured adult spinal cord.Nat. Commun.201451333810.1038/ncomms4338 24569435
     [Google Scholar]
  34. WangL.L. SuZ. TaiW. ZouY. XuX.M. ZhangC.L. The p53 pathway controls SOX2-mediated reprogramming in the adult mouse spinal cord.Cell Rep.201617389190310.1016/j.celrep.2016.09.038 27732862
     [Google Scholar]
  35. IngusciS. HallB.L. GoinsW.F. CohenJ.B. GloriosoJ.C. Viral vectors for gene delivery to the central nervous system.Handb. Clin. Neurol.2024205598110.1016/B978‑0‑323‑90120‑8.00001‑0 39341663
     [Google Scholar]
  36. WangQ. LiW. LeiW. ChenG. XiangZ. XuL. LiuM. Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex.Neural Regen. Res.202116475075610.4103/1673‑5374.295925 33063738
     [Google Scholar]
  37. PulsB. DingY. ZhangF. PanM. LeiZ. PeiZ. JiangM. BaiY. ForsythC. MetzgerM. RanaT. ZhangL. DingX. KeefeM. CaiA. RedillaA. LaiM. HeK. LiH. ChenG. Regeneration of functional neurons after spinal cord injury viain situ NeuroD1-mediated astrocyte-to-neuron conversion.Front. Cell Dev. Biol.2020859188310.3389/fcell.2020.591883 33425896
     [Google Scholar]
  38. BruletR. MatsudaT. ZhangL. MirandaC. GiaccaM. KasparB.K. NakashimaK. HsiehJ. NEUROD1 instructs neuronal conversion in non-reactive astrocytes.Stem Cell Reports2017861506151510.1016/j.stemcr.2017.04.013 28506534
     [Google Scholar]
  39. DuanC.L. LiuC.W. ShenS.W. YuZ. MoJ.L. ChenX.H. SunF.Y. Striatal astrocytes transdifferentiate into functional mature neurons following ischemic brain injury.Glia20156391660167010.1002/glia.22837 26031629
     [Google Scholar]
  40. LiuS. XuX. Omari-SiawE. YuJ. DengW. Progress of reprogramming astrocytes into neuron.Mol. Cell. Neurosci.202413010394710.1016/j.mcn.2024.103947 38862082
     [Google Scholar]
  41. LentzT.B. GrayS.J. SamulskiR.J. Viral vectors for gene delivery to the central nervous system.Neurobiol. Dis.201248217918810.1016/j.nbd.2011.09.014 22001604
     [Google Scholar]
  42. HewettJ.A. Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system.J. Neurochem.200911061717173610.1111/j.1471‑4159.2009.06288.x 19627442
     [Google Scholar]
  43. ZhuoL. TheisM. Alvarez-MayaI. BrennerM. WilleckeK. MessingA. hGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo.Genesis2001312859410.1002/gene.10008 11668683
     [Google Scholar]
  44. JoplingC. BoueS. BelmonteJ.C.I. Dedifferentiation, transdifferentiation and reprogramming: Three routes to regeneration.Nat. Rev. Mol. Cell Biol.2011122798910.1038/nrm3043 21252997
     [Google Scholar]
  45. JanowskaJ. GargasJ. Ziemka-NaleczM. ZalewskaT. BuzanskaL. SypeckaJ. Directed glial differentiation and transdifferentiation for neural tissue regeneration.Exp. Neurol.201931911281310.1016/j.expneurol.2018.08.010 30171864
     [Google Scholar]
  46. SugimoriM. NagaoM. BertrandN. ParrasC.M. GuillemotF. NakafukuM. Combinatorial actions of patterning and HLH transcription factors in the spatiotemporal control of neurogenesis and gliogenesis in the developing spinal cord.Development200713481617162910.1242/dev.001255 17344230
     [Google Scholar]
  47. ZhangL. YinJ.C. YehH. MaN.X. LeeG. ChenX.A. WangY. LinL. ChenL. JinP. WuG.Y. ChenG. Small molecules efficiently reprogram human astroglial cells into functional neurons.Cell Stem Cell201517673574710.1016/j.stem.2015.09.012 26481520
     [Google Scholar]
  48. WangL.L. SerranoC. ZhongX. MaS. ZouY. ZhangC.L. Revisiting astrocyte to neuron conversion with lineage tracing in vivo.Cell20211842154655481.e1610.1016/j.cell.2021.09.005 34582787
     [Google Scholar]
  49. Rivetti di Val CervoP. RomanovR.A. SpigolonG. MasiniD. Martín-MontañezE. ToledoE.M. La MannoG. FeyderM. PiflC. NgY.H. SánchezS.P. LinnarssonS. WernigM. HarkanyT. FisoneG. ArenasE. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson’s disease model.Nat. Biotechnol.201735544445210.1038/nbt.383528398344
     [Google Scholar]
  50. WuZ. ParryM. HouX.Y. LiuM.H. WangH. CainR. PeiZ.F. ChenY.C. GuoZ.Y. AbhijeetS. ChenG. Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington’s disease.Nat. Commun.2020111110510.1038/s41467‑020‑14855‑3 32107381
     [Google Scholar]
  51. LiH. ChenG. In vivo reprogramming for CNS repair: Regenerating neurons from endogenous glial cells.Neuron201691472873810.1016/j.neuron.2016.08.004 27537482
     [Google Scholar]
  52. LatchmanD.S. Transcription factors: An overview.Int. J. Biochem. Cell Biol.199729121305131210.1016/S1357‑2725(97)00085‑X 9570129
     [Google Scholar]
  53. OhoriY. YamamotoS. NagaoM. SugimoriM. YamamotoN. NakamuraK. NakafukuM. Growth factor treatment and genetic manipulation stimulate neurogenesis and oligodendrogenesis by endogenous neural progenitors in the injured adult spinal cord.J. Neurosci.20062646119481196010.1523/JNEUROSCI.3127‑06.2006 17108169
     [Google Scholar]
  54. ZhouQ. BrownJ. KanarekA. RajagopalJ. MeltonD.A. In vivo reprogramming of adult pancreatic exocrine cells to β-cells.Nature2008455721362763210.1038/nature07314 18754011
     [Google Scholar]
  55. JiangM.Q. YuS.P. WeiZ.Z. ZhongW. CaoW. GuX. WuA. McCraryM.R. BerglundK. WeiL. Conversion of reactive astrocytes to induced neurons enhances neuronal repair and functional recovery after ischemic stroke.Front. Aging Neurosci.20211361285610.3389/fnagi.2021.612856 33841125
     [Google Scholar]
  56. TangY. WuQ. GaoM. RyuE. PeiZ. KissingerS.T. ChenY. RaoA.K. XiangZ. WangT. LiW. ChenG. ChubykinA.A. Restoration of visual function and cortical connectivity after ischemic injury through NeuroD1-mediated gene therapy.Front. Cell Dev. Biol.2021972007810.3389/fcell.2021.720078 34490268
     [Google Scholar]
  57. GeL.J. YangF.H. LiW. WangT. LinY. FengJ. ChenN.H. JiangM. WangJ.H. HuX.T. ChenG. In vivo neuroregeneration to treat ischemic stroke through NeuroD1 AAV-based gene therapy in adult non-human primates.Front. Cell Dev. Biol.2020859000810.3389/fcell.2020.590008 33224952
     [Google Scholar]
  58. GresitaA. GlavanD. UdristoiuI. CatalinB. HermannD.M. Popa-WagnerA. Very low efficiency of direct reprogramming of astrocytes into neurons in the brains of young and aged mice after cerebral ischemia.Front. Aging Neurosci.20191133410.3389/fnagi.2019.00334 31849638
     [Google Scholar]
  59. GleichmanA.J. KawaguchiR. SofroniewM.V. CarmichaelS.T. A toolbox of astrocyte-specific, serotype-independent adeno-associated viral vectors using microRNA targeting sequences.Nat. Commun.2023141742610.1038/s41467‑023‑42746‑w 37973910
     [Google Scholar]
  60. SandsM.S. AAV-mediated liver-directed gene therapy.Methods Mol. Biol.201280714115710.1007/978‑1‑61779‑370‑7_6 22034029
     [Google Scholar]
  61. Penaud-BudlooM. FrançoisA. ClémentN. AyusoE. Pharmacology of recombinant adeno-associated virus production.Mol. Ther. Methods Clin. Dev.2018816618010.1016/j.omtm.2018.01.002 29687035
     [Google Scholar]
  62. SamulskiR.J. MuzyczkaN. AAV-mediated gene therapy for research and therapeutic purposes.Annu. Rev. Virol.20141142745110.1146/annurev‑virology‑031413‑085355 26958729
     [Google Scholar]
  63. MasserdottiG. GascónS. GötzM. Direct neuronal reprogramming: Learning from and for development.Development2016143142494251010.1242/dev.092163 27436039
     [Google Scholar]
  64. MattuginiN. BocchiR. ScheussV. RussoG.L. TorperO. LaoC.L. GötzM. Inducing different neuronal subtypes from astrocytes in the injured mouse cerebral cortex.Neuron2019103610861095.e510.1016/j.neuron.2019.08.009 31488328
     [Google Scholar]
  65. VisvanathanJ. LeeS. LeeB. LeeJ.W. LeeS.K. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development.Genes Dev.200721774474910.1101/gad.1519107 17403776
     [Google Scholar]
  66. LuT.X. RothenbergM.E. microRNA.J. Allergy Clin. Immunol.201814141202120710.1016/j.jaci.2017.08.034 29074454
     [Google Scholar]
  67. SmirnovaL. GräfeA. SeilerA. SchumacherS. NitschR. WulczynF.G. Regulation of miRNA expression during neural cell specification.Eur. J. Neurosci.20052161469147710.1111/j.1460‑9568.2005.03978.x 15845075
     [Google Scholar]
  68. SunY. LuoZ.M. GuoX.M. SuD.F. LiuX. An updated role of microRNA-124 in central nervous system disorders: A review.Front. Cell. Neurosci.2015919310.3389/fncel.2015.00193 26041995
     [Google Scholar]
  69. ZhengY. HuangZ. XuJ. HouK. YuY. LvS. ChenL. LiY. QuanC. ChiG. MiR-124 and small molecules synergistically regulate the generation of neuronal cells from rat cortical reactive astrocytes.Mol. Neurobiol.20215852447246410.1007/s12035‑021‑02345‑6 33725319
     [Google Scholar]
  70. PapadimitriouE. KoutsoudakiP.N. ThanouI. KaragkouniD. KaramitrosT. Chroni-TzartouD. GaitanouM. GkemisisC. MargaritiM. XingiE. TzartosS.J. HatzigeorgiouA.G. ThomaidouD. A miR-124-mediated post-transcriptional mechanism controlling the cell fate switch of astrocytes to induced neurons.Stem Cell Reports202318491593510.1016/j.stemcr.2023.02.009 36963393
     [Google Scholar]
  71. MoJ.L. LiuQ. KouZ.W. WuK.W. YangP. ChenX.H. SunF.Y. MicroRNA-365 modulates astrocyte conversion into neuron in adult rat brain after stroke by targeting Pax6.Glia20186671346136210.1002/glia.23308 29451327
     [Google Scholar]
  72. Ghasemi-KasmanM. ShojaeiA. GolM. MoghadamniaA.A. BaharvandH. JavanM. miR-302/367-induced neurons reduce behavioral impairment in an experimental model of Alzheimer’s disease.Mol. Cell. Neurosci.201886505710.1016/j.mcn.2017.11.012 29174617
     [Google Scholar]
  73. XieX. FuY. LiuJ. Chemical reprogramming and transdifferentiation.Curr. Opin. Genet. Dev.20174610411310.1016/j.gde.2017.07.003 28755566
     [Google Scholar]
  74. GaoL. GuanW. WangM. WangH. YuJ. LiuQ. QiuB. YuY. PingY. BianX. ShenL. PeiG. Direct generation of human neuronal cells from adult astrocytes by small molecules.Stem Cell Reports20178353854710.1016/j.stemcr.2017.01.014 28216149
     [Google Scholar]
  75. YinJ.C. ZhangL. MaN.X. WangY. LeeG. HouX.Y. LeiZ.F. ZhangF.Y. DongF.P. WuG.Y. ChenG. Chemical conversion of human fetal astrocytes into neurons through modulation of multiple signaling pathways.Stem Cell Reports201912348850110.1016/j.stemcr.2019.01.003 30745031
     [Google Scholar]
  76. FernandesG.S. SinghR.D. KimK.K. Generation of a pure culture of neuron-like cells with a glutamatergic phenotype from mouse astrocytes.Biomedicines202210492810.3390/biomedicines10040928 35453678
     [Google Scholar]
  77. MaY. XieH. DuX. WangL. JinX. ZhangQ. HanY. SunS. WangL. LiX. ZhangC. WangM. LiC. XuJ. HuangZ. WangX. ChaiZ. DengH. In vivo chemical reprogramming of astrocytes into neurons.Cell Discov.2021711210.1038/s41421‑021‑00243‑8 33649311
     [Google Scholar]
  78. TanZ. QinS. YuanY. HuX. HuangX. LiuH. PuY. HeC. SuZ. NOTCH1 signaling regulates the latent neurogenic program in adult reactive astrocytes after spinal cord injury.Theranostics202212104548456310.7150/thno.71378 35832093
     [Google Scholar]
  79. ShenK. WuD. SunB. ZhuY. WangH. ZouW. MaY. LuZ. Ginsenoside Rg1 promotes astrocyte-to-neuron transdifferentiation in rat and its possible mechanism.CNS Neurosci. Ther.202329125626910.1111/cns.14000 36352836
     [Google Scholar]
  80. ZhaoA.D. QinH. SunM.L. MaK. FuX.B. Efficient and rapid conversion of human astrocytes and ALS mouse model spinal cord astrocytes into motor neuron-like cells by defined small molecules.Mil. Med. Res.2020714210.1186/s40779‑020‑00271‑7 32892745
     [Google Scholar]
  81. WangS. DuanY. ZhangQ. KomarlaA. GongH. GaoW. ZhangL. Drug targeting via platelet membrane–coated nanoparticles.Small Struct.202011200001810.1002/sstr.202000018 33817693
     [Google Scholar]
  82. MaN.X. YinJ.C. ChenG. Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming.Front. Cell Dev. Biol.201978210.3389/fcell.2019.00082 31231645
     [Google Scholar]
  83. MaimonR. Chillon-MarinasC. SnethlageC.E. SinghalS.M. McAlonis-DownesM. LingK. RigoF. BennettC.F. Da CruzS. HnaskoT.S. MuotriA.R. ClevelandD.W. Therapeutically viable generation of neurons with antisense oligonucleotide suppression of PTB.Nat. Neurosci.20212481089109910.1038/s41593‑021‑00864‑y 34083786
     [Google Scholar]
  84. QianH. KangX. HuJ. ZhangD. LiangZ. MengF. ZhangX. XueY. MaimonR. DowdyS.F. DevarajN.K. ZhouZ. MobleyW.C. ClevelandD.W. FuX.D. Reversing a model of Parkinson’s disease with in situ converted nigral neurons.Nature2020582781355055610.1038/s41586‑020‑2388‑4 32581380
     [Google Scholar]
  85. ZhouH. SuJ. HuX. ZhouC. LiH. ChenZ. XiaoQ. WangB. WuW. SunY. ZhouY. TangC. LiuF. WangL. FengC. LiuM. LiS. ZhangY. XuH. YaoH. ShiL. YangH. Glia-to-neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice.Cell20201813590603.e1610.1016/j.cell.2020.03.024 32272060
     [Google Scholar]
  86. XueY. QianH. HuJ. ZhouB. ZhouY. HuX. KarakhanyanA. PangZ. FuX.D. Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells.Nat. Neurosci.201619680781510.1038/nn.4297 27110916
     [Google Scholar]
  87. ManuelM.N. MiD. MasonJ.O. PriceD.J. Regulation of cerebral cortical neurogenesis by the Pax6 transcription factor.Front. Cell. Neurosci.201597010.3389/fncel.2015.00070 25805971
     [Google Scholar]
  88. WeinbergM.S. CriswellH.E. PowellS.K. BhattA.P. McCownT.J. Viral vector reprogramming of adult resident striatal oligodendrocytes into functional neurons.Mol. Ther.201725492893410.1016/j.ymthe.2017.01.016 28202388
     [Google Scholar]
  89. HoangT. KimD.W. AppelH. OzawaM. ZhengS. KimJ. BlackshawS. Ptbp1 deletion does not induce astrocyte-to-neuron conversion.Nature20236187964E1E710.1038/s41586‑023‑06066‑9 37286658
     [Google Scholar]
  90. Amador-ArjonaA. CimadamoreF. HuangC.T. WrightR. LewisS. GageF.H. TerskikhA.V. SOX2 primes the epigenetic landscape in neural precursors enabling proper gene activation during hippocampal neurogenesis.Proc. Natl. Acad. Sci. USA201511215E1936E194510.1073/pnas.1421480112 25825708
     [Google Scholar]
  91. NiuW. ZangT. SmithD.K. VueT.Y. ZouY. BachooR. JohnsonJ.E. ZhangC.L. SOX2 reprograms resident astrocytes into neural progenitors in the adult brain.Stem Cell Reports20154578079410.1016/j.stemcr.2015.03.006 25921813
     [Google Scholar]
  92. MasserdottiG. GillotinS. SutorB. DrechselD. IrmlerM. JørgensenH.F. SassS. TheisF.J. BeckersJ. BerningerB. GuillemotF. GötzM. Transcriptional mechanisms of proneural factors and REST in regulating neuronal reprogramming of astrocytes.Cell Stem Cell2015171748810.1016/j.stem.2015.05.014 26119235
     [Google Scholar]
  93. GuillemotF. Spatial and temporal specification of neural fates by transcription factor codes.Development2007134213771378010.1242/dev.006379 17898002
     [Google Scholar]
  94. RaoZ. WangR. LiS. ShiY. MoL. HanS. YuanJ. JingN. ChengL. Molecular mechanisms underlying Ascl1-mediated astrocyte-to-neuron conversion.Stem Cell Reports202116353454710.1016/j.stemcr.2021.01.006 33577795
     [Google Scholar]
  95. BocchiR. MasserdottiG. GötzM. Direct neuronal reprogramming: Fast forward from new concepts toward therapeutic approaches.Neuron2022110336639310.1016/j.neuron.2021.11.023 34921778
     [Google Scholar]
  96. SmithD.K. YangJ. LiuM.L. ZhangC.L. Small molecules modulate chromatin accessibility to promote NEUROG2-mediated fibroblast-to-neuron reprogramming.Stem Cell Reports20167595596910.1016/j.stemcr.2016.09.013 28157484
     [Google Scholar]
  97. MallM. KaretaM.S. ChandaS. AhleniusH. PerottiN. ZhouB. GriederS.D. GeX. DrakeS. Euong AngC. WalkerB.M. VierbuchenT. FuentesD.R. BrenneckeP. NittaK.R. JolmaA. SteinmetzL.M. TaipaleJ. SüdhofT.C. WernigM. Myt1l safeguards neuronal identity by actively repressing many non-neuronal fates.Nature2017544764924524910.1038/nature21722 28379941
     [Google Scholar]
  98. TreutleinB. LeeQ.Y. CampJ.G. MallM. KohW. ShariatiS.A.M. SimS. NeffN.F. SkotheimJ.M. WernigM. QuakeS.R. Dissecting direct reprogramming from fibroblast to neuron using single-cell RNA-seq.Nature2016534760739139510.1038/nature18323 27281220
     [Google Scholar]
  99. LinH.C. HeZ. EbertS. SchörnigM. SantelM. NikolovaM.T. WeigertA. HeversW. KasriN.N. TavernaE. CampJ.G. TreutleinB. NGN2 induces diverse neuron types from human pluripotency.Stem Cell Reports20211692118212710.1016/j.stemcr.2021.07.006 34358451
     [Google Scholar]
  100. BaumannV. WiesbeckM. BreunigC.T. BraunJ.M. KöferleA. NinkovicJ. GötzM. StrickerS.H. Targeted removal of epigenetic barriers during transcriptional reprogramming.Nat. Commun.2019101211910.1038/s41467‑019‑10146‑8 31073172
     [Google Scholar]
  101. KempfJ. KnellesK. HersbachB.A. PetrikD. RiedemannT. BednarovaV. JanjicA. Simon-EbertT. EnardW. SmialowskiP. GötzM. MasserdottiG. Heterogeneity of neurons reprogrammed from spinal cord astrocytes by the proneural factors Ascl1 and Neurogenin2.Cell Rep.202136710957110.1016/j.celrep.2021.109571 34407409
     [Google Scholar]
  102. ParryA. RulandsS. ReikW. Active turnover of DNA methylation during cell fate decisions.Nat. Rev. Genet.2021221596610.1038/s41576‑020‑00287‑8 33024290
     [Google Scholar]
  103. LiG. LiuY. ZhangY. KuboN. YuM. FangR. KellisM. RenB. Joint profiling of DNA methylation and chromatin architecture in single cells.Nat. Methods2019161099199310.1038/s41592‑019‑0502‑z 31384045
     [Google Scholar]
  104. LeeD.S. LuoC. ZhouJ. ChandranS. RivkinA. BartlettA. NeryJ.R. FitzpatrickC. O’ConnorC. DixonJ.R. EckerJ.R. Simultaneous profiling of 3D genome structure and DNA methylation in single human cells.Nat. Methods20191610999100610.1038/s41592‑019‑0547‑z 31501549
     [Google Scholar]
  105. NoackF. VangelistiS. RafflG. CaridoM. DiwakarJ. ChongF. BonevB. Multimodal profiling of the transcriptional regulatory landscape of the developing mouse cortex identifies Neurog2 as a key epigenome remodeler.Nat. Neurosci.202225215416710.1038/s41593‑021‑01002‑4 35132236
     [Google Scholar]
  106. PriceJ.D. ParkK.Y. ChenJ. SalinasR.D. ChoM.J. KriegsteinA.R. LimD.A. The Ink4a/Arf locus is a barrier to direct neuronal transdifferentiation.J. Neurosci.20143437125601256710.1523/JNEUROSCI.3159‑13.2014 25209293
     [Google Scholar]
  107. YangS. QinC. HuZ.W. ZhouL.Q. YuH.H. ChenM. BoscoD.B. WangW. WuL.J. TianD.S. Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system.Neurobiol. Dis.202115210529010.1016/j.nbd.2021.105290 33556540
     [Google Scholar]
  108. WangH. YangY. LiuJ. QianL. Direct cell reprogramming: Approaches, mechanisms and progress.Nat. Rev. Mol. Cell Biol.202122641042410.1038/s41580‑021‑00335‑z 33619373
     [Google Scholar]
  109. BuffoA. RiteI. TripathiP. LepierA. ColakD. HornA.P. MoriT. GötzM. Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.Proc. Natl. Acad. Sci. USA200810593581358610.1073/pnas.0709002105 18299565
     [Google Scholar]
  110. LangB. LiuH.L. LiuR. FengG.D. JiaoX.Y. JuG. Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells.Neuroscience2004128477578310.1016/j.neuroscience.2004.06.033 15464285
     [Google Scholar]
  111. ShimadaI.S. LeComteM.D. GrangerJ.C. QuinlanN.J. SpeesJ.L. Self-renewal and differentiation of reactive astrocyte-derived neural stem/progenitor cells isolated from the cortical peri-infarct area after stroke.J. Neurosci.201232237926794010.1523/JNEUROSCI.4303‑11.2012 22674268
     [Google Scholar]
  112. SirkoS. BehrendtG. JohanssonP.A. TripathiP. CostaM.R. BekS. HeinrichC. TiedtS. ColakD. DichgansM. FischerI.R. PlesnilaN. StaufenbielM. HaassC. SnapyanM. SaghatelyanA. TsaiL.H. FischerA. GrobeK. DimouL. GötzM. Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected].Cell Stem Cell201312442643910.1016/j.stem.2013.01.019 23561443
     [Google Scholar]
  113. SirkoS. NeitzA. MittmannT. Horvat-BröckerA. HolstA. EyselU.T. FaissnerA. Focal laser-lesions activate an endogenous population of neural stem/progenitor cells in the adult visual cortex.Brain200913282252226410.1093/brain/awp043 19286696
     [Google Scholar]
  114. MagnussonJ.P. GöritzC. TatarishviliJ. DiasD.O. SmithE.M.K. LindvallO. KokaiaZ. FrisénJ. A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse.Science2014346620623724110.1126/science.346.6206.237 25301628
     [Google Scholar]
  115. ShenS.W. DuanC.L. ChenX.H. WangY.Q. SunX. ZhangQ.W. CuiH.R. SunF.Y. Neurogenic effect of VEGF is related to increase of astrocytes transdifferentiation into new mature neurons in rat brains after stroke.Neuropharmacology201610845146110.1016/j.neuropharm.2015.11.012 26603138
     [Google Scholar]
  116. GrandeA. SumiyoshiK. López-JuárezA. HowardJ. SakthivelB. AronowB. CampbellK. NakafukuM. Environmental impact on direct neuronal reprogramming in vivo in the adult brain.Nat. Commun.201341237310.1038/ncomms3373 23974433
     [Google Scholar]
  117. YamashitaT. ShangJ. NakanoY. MoriharaR. SatoK. TakemotoM. HishikawaN. OhtaY. AbeK. In vivo direct reprogramming of glial linage to mature neurons after cerebral ischemia.Sci. Rep.2019911095610.1038/s41598‑019‑47482‑0 31358888
     [Google Scholar]
  118. LiG. ChenB. SunW. LiuZ. A stacking classifier for distinguishing stages of Alzheimer’s disease from a subnetwork perspective.Cogn. Neurodynamics20251913810.1007/s11571‑025‑10221‑5 39926335
     [Google Scholar]
  119. Yavarpour-BaliH. Ghasemi-KasmanM. ShojaeiA. Direct reprogramming of terminally differentiated cells into neurons: A novel and promising strategy for Alzheimer’s disease treatment.Prog. Neuropsychopharmacol. Biol. Psychiatry20209810982010.1016/j.pnpbp.2019.109820 31743695
     [Google Scholar]
  120. LiuF. ZhangY. ChenF. YuanJ. LiS. HanS. LuD. GengJ. RaoZ. SunL. XuJ. ShiY. WangX. LiuY. Neurog2 directly converts astrocytes into functional neurons in midbrain and spinal cord.Cell Death Dis.202112322510.1038/s41419‑021‑03498‑x 33649354
     [Google Scholar]
  121. BrownR.H. Al-ChalabiA. Amyotrophic Lateral Sclerosis.N. Engl. J. Med.2017377216217210.1056/NEJMra1603471 28700839
     [Google Scholar]
  122. YangH. LiuC. WangC.Y. ZhangQ. AnJ. ZhangL. HaoD.J. Therapeutical strategies for spinal cord injury and a promising autologous astrocyte-based therapy using efficient reprogramming techniques.Mol. Neurobiol.20165352826284210.1007/s12035‑015‑9157‑7 25863960
     [Google Scholar]
  123. LiuZ. ChoppM. Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.Prog. Neurobiol.201614410312010.1016/j.pneurobio.2015.09.008 26455456
     [Google Scholar]
  124. SunL. ZhangY. LiuE. MaQ. AnatolM. HanH. YanJ. The roles of astrocyte in the brain pathologies following ischemic stroke.Brain Inj.201933671271610.1080/02699052.2018.1531311 30335519
     [Google Scholar]
  125. XuJ. DuY. DengH. Direct lineage reprogramming: Strategies, mechanisms, and applications.Cell Stem Cell201516211913410.1016/j.stem.2015.01.013 25658369
     [Google Scholar]
  126. McDowallS. BagdaV. HodgettsS. MastagliaF. LiD. Controversies and insights into PTBP1-related astrocyte-neuron transdifferentiation: Neuronal regeneration strategies for Parkinson’s and Alzheimer’s disease.Transl. Neurodegener.20241315910.1186/s40035‑024‑00450‑9 39627843
     [Google Scholar]
  127. GhazaleH. ParkE. VasanL. MesterJ. SalehF. TrevisiolA. ZinykD. ChinchalongpornV. LiuM. FlemingT. ProkopchukO. KleninN. KurraschD. FaizM. StefanovicB. McLaurinJ. SchuurmansC. Ascl1 phospho-site mutations enhance neuronal conversion of adult cortical astrocytes in vivo.Front. Neurosci.20221691707110.3389/fnins.2022.917071 36061596
     [Google Scholar]
  128. MarichalN. PéronS. Beltrán ArranzA. GalanteC. Franco ScaranteF. WiffenR. SchuurmansC. KarowM. GascónS. BerningerB. Reprogramming astroglia into neurons with hallmarks of fast-spiking parvalbumin-positive interneurons by phospho-site-deficient Ascl1.Sci. Adv.20241043eadl593510.1126/sciadv.adl5935 39454007
     [Google Scholar]
  129. LanjakornsiripanD. PiorB.J. KawaguchiD. FurutachiS. TaharaT. KatsuyamaY. SuzukiY. FukazawaY. GotohY. Layer-specific morphological and molecular differences in neocortical astrocytes and their dependence on neuronal layers.Nat. Commun.201891162310.1038/s41467‑018‑03940‑3 29691400
     [Google Scholar]
  130. SuM. HuH. LeeY. D’AzzoA. MessingA. BrennerM. Expression specificity of GFAP transgenes.Neurochem. Res.200429112075209310.1007/s11064‑004‑6881‑1 15662842
     [Google Scholar]
  131. TaiW. WuW. WangL.L. NiH. ChenC. YangJ. ZangT. ZouY. XuX.M. ZhangC.L. In vivo reprogramming of NG2 glia enables adult neurogenesis and functional recovery following spinal cord injury.Cell Stem Cell2021285923937.e410.1016/j.stem.2021.02.009 33675690
     [Google Scholar]
  132. ChenW. ZhengQ. HuangQ. MaS. LiM. Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease.eLife202211e7563610.7554/eLife.75636 35535997
     [Google Scholar]
  133. AngC.E. WernigM. Induced neuronal reprogramming.J. Comp. Neurol.2014522122877288610.1002/cne.23620 24771471
     [Google Scholar]
  134. MirakhoriF. ZeynaliB. SalekdehG.H. BaharvandH. Induced neural lineage cells as repair kits: So close, yet so far away.J. Cell. Physiol.2014229672874210.1002/jcp.24509 24242901
     [Google Scholar]
  135. ShiriZ. SimorghS. NaderiS. BaharvandH. Optogenetics in the era of cerebral organoids.Trends Biotechnol.201937121282129410.1016/j.tibtech.2019.05.009 31227305
     [Google Scholar]
  136. FiorenzanoA. SozziE. BirteleM. KajtezJ. GiacomoniJ. NilssonF. BruzeliusA. SharmaY. ZhangY. MattssonB. EmnéusJ. OttossonD.R. StormP. ParmarM. Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids.Nat. Commun.2021121730210.1038/s41467‑021‑27464‑5 34911939
     [Google Scholar]
  137. XiaoshuaiL. QiushiW. RuiW. Advantages of CRISPR-Cas9 combined organoid model in the study of congenital nervous system malformations.Front. Bioeng. Biotechnol.20221093293610.3389/fbioe.2022.932936 36118578
     [Google Scholar]
  138. YangY. LiQ. GuoX. TuJ. ZhangD. Mechanisms underlying sonoporation: Interaction between microbubbles and cells.Ultrason. Sonochem.20206710509610.1016/j.ultsonch.2020.105096 32278246
     [Google Scholar]
  139. DarriguesE. NimaZ.A. GriffinR.J. AndersonJ.M. BirisA.S. RodriguezA. 3D cultures for modeling nanomaterial-based photothermal therapy.Nanoscale Horiz.20205340043010.1039/C9NH00628A 32118219
     [Google Scholar]
  140. QianC. DongB. WangX.Y. ZhouF.Q. In vivo glial trans-differentiation for neuronal replacement and functional recovery in central nervous system.FEBS J.2021288164773478510.1111/febs.15681 33351267
     [Google Scholar]
/content/journals/cn/10.2174/011570159X379061250415094751
Loading
The Mechanisms and Application Prospects of Astrocyte Reprogramming into Neurons in Central Nervous System Diseases
Curr. Neuropharmacol. 24, 58 (2026); https://doi.org/10.2174/011570159X379061250415094751
/content/journals/cn/10.2174/011570159X379061250415094751
/content/journals/cn/10.2174/011570159X379061250415094751
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Astrocyte reprogramming; CNS diseases; induced neurons (iNs); MicroRNAs; neurological recovery; small molecules; transcription factors

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test